Regulatory PathRegulatory requirements compared

Active substances

Ethinylestradiol + Levonorgestrel

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
LOGYNON TAB30,125 µg,µgTablet · Oral use21 BlisterSAR 12.10NCE · PrescriptionBAYER AGValid
MICROGYNON-30 21TAB30,150 µgTablet · Oral use21 BlisterSAR 11.45Generic · PrescriptionBAYER SCHERING PHARMAWithdrawn by MAH · Not Marketed
NEOGYNON TAB0.050, 0.25 mgTablet · Oral use21 BlisterSAR 11.45Generic · PrescriptionBAYER SCHERING PHARMAWithdrawn by MAH · Not Marketed
NORDETTE 21TAB0.03, 0.15 mgTablet · Oral use21 BlisterSAR 11.45Generic · PrescriptionWYETHWithdrawn by MAH · Not Marketed
NORDIOL 21TAB50, 0.25 µgTablet · Oral use21 BlisterSAR 11.45Generic · PrescriptionWYETHWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

CONTRACEPTION; ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
LEVORA 0.15/30-280.03MG;0.15MGtablet · oral-28DR REDDYS LABS SAPrescription13 Dec 1993
TRIVORA-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGtablet · oral-28DR REDDYS LABS SAPrescription18 Dec 1997
AVIANE-280.02MG;0.1MGtablet · oral-28DURAMED PHARMS BARRPrescription30 Apr 2001
ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGtablet · oral-28DURAMED PHARMS BARRPrescription16 Jul 2001
LESSINA-280.02MG;0.1MGtablet · oral-28BARRPrescription20 Mar 2002
PORTIA-280.03MG;0.15MGtablet · oral-28BARRPrescription23 May 2002
SEASONALE0.03MG;0.15MGtablet · oralTEVA BRANDED PHARMPrescription5 Sep 2003
LEVONORGESTREL AND ETHINYL ESTRADIOL0.02MG;0.1MGtablet · oral-28DR REDDYS LABS SAPrescription18 Nov 2004
SEASONIQUE0.03MG,0.01MG;0.15MG,N/Atablet · oralTEVA BRANDED PHARMPrescription25 May 2006
LEVONORGESTREL AND ETHINYL ESTRADIOL0.02MG;0.1MGtablet · oral-28DR REDDYS LABS SAPrescription31 May 2006
QUASENSE0.03MG;0.15MGtablet · oralWATSON LABSPrescription6 Sep 2006
LOSEASONIQUE0.02MG,0.1MG;0.01MG,N/Atablet · oralTEVA BRANDED PHARMPrescription24 Oct 2008
ALTAVERA0.03MG;0.15MGtablet · oral-28XIROMEDPrescription3 Aug 2010
INTROVALE0.03MG;0.15MGtablet · oralXIROMEDPrescription27 Sep 2010
LEVONEST0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGtablet · oral-28NOVAST LABS LTDPrescription29 Dec 2010
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL0.03MG,0.01MG;0.15MG,N/Atablet · oralDR REDDYS LABS SAPrescription31 May 2011
LEVONORGESTREL AND ETHINYL ESTRADIOL0.02MG;0.09MGtablet · oralWATSON LABSPrescription6 Jun 2011
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL0.02MG,0.1MG;0.01MG,N/Atablet · oralLUPIN LTDPrescription26 Oct 2011
MARLISSA0.03MG;0.15MGtablet · oral-28GLENMARK PHARMS LTDPrescription29 Feb 2012
FALMINA0.02MG;0.1MGtablet · oral-28NOVAST LABS LTDPrescription28 Mar 2012
KURVELO0.03MG;0.15MGtablet · oral-28LUPIN LTDPrescription17 Oct 2012
LEVONORGESTREL AND ETHINYL ESTRADIOL0.03MG;0.15MGtablet · oralLUPIN LTDPrescription23 Oct 2012
LEVONORGESTREL AND ETHINYL ESTRADIOL0.03MG;0.15MGtablet · oral-28XIROMEDPrescription21 Dec 2012
LEVONORGESTREL AND ETHINYL ESTRADIOL0.02MG;0.1MGtablet · oral-28LUPIN LTDPrescription18 Jan 2013
QUARTETTE0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/Atablet · oralTEVA BRANDED PHARMPrescription28 Mar 2013

59 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ALESSE 2102236974100 MCG; 20 MCGTABLET · ORALPFIZER CANADA ULC
ALESSE 280223697520 MCG; 100 MCGTABLET · ORALPFIZER CANADA ULC
ALYSENA 2102387875100 MCG; 20 MCGTABLET · ORALAPOTEX INC
ALYSENA 280238788320 MCG; 100 MCGTABLET · ORALAPOTEX INC
AUDRINA 210253217420 MCG; 100 MCGTABLET · ORALJAMP PHARMA CORPORATION
AUDRINA 280253218220 MCG; 100 MCGTABLET · ORALJAMP PHARMA CORPORATION
AVIANE 210229853820 MCG; 100 MCGTABLET · ORALTEVA CANADA LIMITED
AVIANE 2802298546100 MCG; 20 MCGTABLET · ORALTEVA CANADA LIMITED
INDAYO023988690.15 MG; 0.03 MGTABLET · ORALSENADOR LABORATORIES PRIVATE LIMITED
LAYLAA 2102424282100 MCG; 20 MCGTABLET · ORALLUPIN PHARMA CANADA LIMITED
LAYLAA 280242429020 MCG; 100 MCGTABLET · ORALLUPIN PHARMA CANADA LIMITED
MIN-OVRAL 210204232030 MCG; 150 MCGTABLET · ORALPFIZER CANADA ULC
MIN-OVRAL 2802042339150 MCG; 30 MCGTABLET · ORALPFIZER CANADA ULC
OVIMA 210238708530 MCG; 150 MCGTABLET · ORALAPOTEX INC
OVIMA 280238709330 MCG; 150 MCGTABLET · ORALAPOTEX INC
PORTIA 21022959460.03 MG; 0.15 MGTABLET · ORALTEVA CANADA LIMITED
PORTIA 28022959540.15 MG; 0.03 MGTABLET · ORALTEVA CANADA LIMITED
SEASONALE022966590.15 MG; 0.03 MGTABLET · ORALTEVA CANADA LIMITED
SEASONIQUE023461760.15 MG; 0.01 MG; 0.03 MGTABLET · ORALTEVA CANADA LIMITED
TRIQUILAR 210070760040 MCG; 125 MCG; 30 MCG; 50 MCG; 75 MCGTABLET · ORALBAYER INC
TRIQUILAR 280070750350 MCG; 30 MCG; 125 MCG; 40 MCG; 75 MCGTABLET · ORALBAYER INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACALTAVERA-28 TABLET$0.11352per EA23 Sep 2026
US NADACASHLYNA 0.15-0.03-0.01 MG TAB$0.12477per EA23 Sep 2026
US NADACAYUNA-28 TABLET$0.11352per EA23 Sep 2026
US NADACBALCOLTRA TABLET$10.03814per EA1 Jan 2026
US NADACDAYSEE 0.15-0.03-0.01 MG TAB$0.12477per EA23 Sep 2026
US NADACDOLISHALE 90-20 MCG TABLET$1.13572per EA23 Sep 2026
US NADACFALMINA-28 TABLET$0.15354per EA23 Sep 2026
US NADACINTROVALE 0.15-0.03 MG TABLET$0.22674per EA23 Sep 2026
US NADACJAIMIESS 0.15-0.03-0.01 MG TAB$0.12477per EA23 Sep 2026
US NADACKURVELO-28 TABLET$0.11352per EA23 Sep 2026
US NADACLEVONEST-28 TABLET$0.32363per EA23 Sep 2026
US NADACMARLISSA-28 TABLET$0.11352per EA23 Sep 2026
NHS Drug TariffEthinylestradiol 30microgram / Levonorgestrel 150microgram tablets£2.8263 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 22.1.1. Oral hormonal contraceptives · core
    Contact with health services for contraceptive management
    Oral > Solid: 30 µg + 150 µg

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.